The assessment of neuronal activation using cFos as a surrogate marker in response to an acute administration of cagrilintide and sCT in chow-fed mice revealed that both cagrilintide and sCT produced a significantly higher cFos signal compared to vehicle-treated mice, showing similar activation patterns in WT mice AP, NTS and LPBN brain areas
Product & Safety Guidance Apply a small amount of the product onto a clean area of skin on the upper forearm
Sample Packaging is included in attachments- Packaging is for Patches that will come in a "Pouch" as seen in the attachment "Stock Peptide Patch Picture"
Long-term use safety Traditional pain meds: Not safe for years of continuous use Require breaks or rotation Accumulating damage to organs Peptides: Can use for months to years safely BPC-157 and TB-500 have decades of use data No cumulative toxicity Actually heal tissue rather than damage it Combining peptides with pain medications Can use together: Peptides for healing NSAIDs for acute breakthrough pain Reduce medication dose as peptides work Transition plan: Start peptides while on pain meds As pain improves, reduce medication slowly Goal: Minimal or no pain meds long-term See our peptide safety and risks guide

News Release May 05, 2002 Study finds supplement users avoid prescription drugs due to side effects, not cost Brands top rated by users also identified in new survey by ConsumerLab.com WHITE PLAINS, NY March 5, 2002 ConsumerLab.com, traditionally known for its independent laboratory evaluations of dietary supplements and nutritional products, announced surprising findings today from a new survey of supplement users